AstraZeneca/Oxford Covid vaccine shows 70% efficacy, finds d
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Oxford University and pharmaceutical giant AstraZeneca said on 22 November that the coronavirus vaccine being developed by them has shown 70% efficiency. Oxford-AstraZeneca further said that the vaccine could be around 90 per cent effective under "one dosing regimen".

A press note released by the Oxford University stated, "Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens".

"In the two different dose regimens, vaccine efficacy was 90% in one, and 62% in the other," the release on interim trial data from Phase III trials further said.

"Early indication that vaccine could reduce virus transmission from an observed reduction in asymptomatic infections," it added.

The Oxford release also mentioned that there were no hospitalised or severe cases in anyone who received the vaccine.

Oxford and AstraZeneca are waiting for the results of phase III trials of their coronavirus vaccine candidate 'AZD1222' on thousands of people around the world to show whether their vaccine is safe and effective.

Oxford-AstraZeneca findings come days after two other drugmakers, Pfizer and Moderna, reported preliminary results from late-stage trials showing that their Covid-19 vaccines were almost 95% effective.

Source: https://www.indiatoday.in/coronavirus-outbreak/story/covid19-oxford-astrazeneca-coronavirus-vaccine-shows-70-efficacy-1743256-2020-11-23
Dr. M●●●●●v D●●●i and 1 others like this1 share
Like
Comment
Share